1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow FutureChem: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application [177Lu]Ludotadipep 3.7 GBq - Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Unknown | FutureChem | 26 | 2022-09-01 | 2024-04-29 |
| [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer [18F]FLOR (FC303) Injection - Metastatic Prostate Cancer | Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 | 2021-02-01 | 2024-01-16 |
| [177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer. [177Lu]Ludotadipep - Metastatic Castration-resistant Prostate Cancer | Phase 1 | Completed | FutureChem | 30 | 2020-10-14 | 2022-10-20 |
Injections (1)
United States (2) · South Korea (1)
Arif Hussain, MD (1) · Ji Youl Lee (1) · Steven Rowe, M.D., Ph.D. (1)